As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that ...

As RFK Jr.'s new vaccine panel ponders changing the hepatitis B vaccination schedule, some doctors recall past patients, ...

This "really raises a lot of alarm bells about the patients we're missing," researcher say ...

Despite untreated HBV being linked to earlier mortality, higher all-cause and liver-related death, and a 10% to 25% lifetime risk of developing hepatocellular carcinoma (HCC), only 29% of qualifying ...

The World Health Organization has issued its first-ever hepatitis B guidelines that outline how to determine who needs treatment, what medicines to use and how to monitor patients long-term. The ...

Many patients with chronic hepatitis B are deficient in their understanding of the lifelong disease and often do not comply with the drug regimens necessary to control it, according to a new UCLA ...

In a pair of articles published in Lancet Gastroenterology & Hepatology, scientists lay out the case for why we should expand treatment recommendations for people with hepatitis B. Subscribe to our ...

The new chair of the Advisory Committee on Immunization Practices said the panel plans to vote to end universal hepatitis B ...

Spontaneous loss of hepatitis B e antigen (HBeAg) followed by seroconversion to anti-HBe usually coincides with normalization of serum alanine aminotransferase (ALT) levels, reduction in HBV DNA in ...

Whether hepatitis resolves depends on the type and whether a person receives treatment. Hepatitis A usually resolves without medications, and while sometimes hepatitis B and C may last only a few ...

Hepatitis B testing can show whether you have a current or past HBV infection and whether you have antibodies from a hepatitis B vaccine. Hepatitis B is a viral infection caused by the hepatitis B ...

A combination treatment involving tobevibart and elebsiran significantly improved disease activity in adults with chronic ...